Income Taxes	9 Months Ended
Sep. 30, 2013
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes: The provision for income taxes for the three months ended September 30, 2013 and 2012 were $113,000 and $57,000, respectively. The provision for income taxes for the nine months ended September 30, 2013 and 2012 were $256,000 and $148,000, respectively. The difference between the statutory rate and the Company’s effective tax rate is primarily due to the impact of foreign taxes, changes in the valuation allowance on deferred tax assets, and changes in the accruals related to unrecognized tax benefits. As of September 30, 2013 and December 31, 2012, the Company had gross unrecognized tax benefits of approximately $2.4 million and $3.4 million, respectively, of which $585,000 and $670,000, respectively, if recognized, would impact the effective tax rate on income from continuing operations. The Company’s policy is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. As of September 30, 2013 and December 31, 2012, the Company had accrued $122,000 and $140,000, respectively, for interest and penalties. The $18,000 reduction in gross unrecognized tax benefits during the nine months ended September 30, 2013 was primarily attributable to the expiration of the statute of limitations in certain foreign jurisdictions. On January 2, 2013, the President signed into law the American Taxpayer Relief Act of 2012, or ATRA. Under prior law, a taxpayer was entitled to a research tax credit for qualifying amount incurred through December 31, 2011. The ATRA extends the research credit for two years for qualified research expenditures incurred through the end of 2013. The extension of the research credit is retroactive and includes amounts incurred after 2011.

Income Taxes

9 Months Ended

Sep. 30, 2013

11. Income Taxes:

The provision for income taxes for the three months ended September 30, 2013 and 2012 were $113,000 and $57,000, respectively. The provision for income taxes for the nine months ended September 30, 2013 and 2012 were $256,000 and $148,000, respectively. The difference between the statutory rate and the Company’s effective tax rate is primarily due to the impact of foreign taxes, changes in the valuation allowance on deferred tax assets, and changes in the accruals related to unrecognized tax benefits.

As of September 30, 2013 and December 31, 2012, the Company had gross unrecognized tax benefits of approximately $2.4 million and $3.4 million, respectively, of which $585,000 and $670,000, respectively, if recognized, would impact the effective tax rate on income from continuing operations. The Company’s policy is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. As of September 30, 2013 and December 31, 2012, the Company had accrued $122,000 and $140,000, respectively, for interest and penalties. The $18,000 reduction in gross unrecognized tax benefits during the nine months ended September 30, 2013 was primarily attributable to the expiration of the statute of limitations in certain foreign jurisdictions.

On January 2, 2013, the President signed into law the American Taxpayer Relief Act of 2012, or ATRA. Under prior law, a taxpayer was entitled to a research tax credit for qualifying amount incurred through December 31, 2011. The ATRA extends the research credit for two years for qualified research expenditures incurred through the end of 2013. The extension of the research credit is retroactive and includes amounts incurred after 2011.